Skip to main content

Obinutuzumab User Reviews & Ratings

Brand names: Gazyva

Obinutuzumab has an average rating of 9.5 out of 10 from a total of 3 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.

Condition Avg. Rating Reviews Compare
Follicular Lymphoma  
9.5
 2 reviews for Follicular Lymphoma 16 medications
Chronic Lymphocytic Leukemia  
1 reviews for Chronic Lymphocytic Leukemia 27 medications
Add your review
  • treat...
  • Taken for 6 months to 1 year
  • October 10, 2022

For Follicular Lymphoma "I was diagnosed with stage 4 follicular lymphoma in December 2021 and received 6 months Chemotherapy of Obinutuzumab + Bendomustine. All went well except for tiredness, especially towards the end of the 6-month cycle, and a lot of "burping". Scans showed that I am now in partial remission. I have since had two treatments of maintenance therapy and am starting to feel well again. I am very grateful to all the people who have developed such lifesaving therapy."

10 / 10
Was this helpful?YesNo
1 Report
  • Buck
  • Taken for 2 to 5 years
  • May 26, 2022

For Follicular Lymphoma "I received Obinutuzumab plus Bendamustine for Follicular Lymphoma. After 6 months of treatment, the lymphoma went into remission. Then I continued on with Obinutuzumab only for 2 years. I mostly struggled with fatigue, bloating, uti’s and bladder pain, shortness of breath, and occasional headaches. The medication was administered through my port every 8 weeks once I was on maintenance."

9 / 10
Was this helpful?YesNo
1 Report
  • Happy
  • August 24, 2019

Gazyva (obinutuzumab) for Chronic Lymphocytic Leukemia "I was very happy with the results. I was up to 83,000 white count and after the first treatment it was down to 5,300. After one month it was still down. I go back in Sept. For my next blood test."

Was this helpful?YesNo
10 Report

Frequently asked questions

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.